Status:
COMPLETED
Efficacy of the Mobile Application for Prediction and Prevention of Mood Episode Recurrence Based on Machine Learning
Lead Sponsor:
Hucircadian
Collaborating Sponsors:
Korea University Guro Hospital
Korea University Ansan Hospital
Conditions:
Major Depressive Disorder
Bipolar 1 Disorder
Eligibility:
All Genders
19-70 years
Phase:
NA
Brief Summary
This study was designed to evaluate the efficacy of the mobile application named Circadian Rhythm for Mood (CRM), which was developed to prevent recurring episodes of mood disorders (major depressive ...
Eligibility Criteria
Inclusion
- Male and female patients, 19-70 years old
- Diagnosis with Bipolar I disorder, Bipolar II disorder, Major depressive disorder based on DSM-5 criteria, in euthymic state for more than two weeks at the time of the recruitment
- Android smartphone users, capable of installing and executing the CRM application
- Consent to wear wearable device (Fitbit) continuously and synchronize and backup data regularly
Exclusion
- Patients who have not experienced major depressive, manic, or hypomanic episode in the last two years
- Patients who are difficult to specify mood episode or evaluate symptoms of mood episode independently due to personality traits (borderline personality trait, cyclothymic temperament, etc.)
- Patients with degenerative neurological disorders (Parkinson's disease, dementia, Huntington's disease, etc.), neurodevelopmental disorders (intellectual disorder, autism spectrum disorder, down syndrome, etc.), epilepsy, severe traumatic brain damage, stroke, and other brain neurological disorders
- Inmates or patients who are forced into custody for the treatment of mental or physical illness (non-voluntary isolation or hospitalization)
- Patients with difficulties in understanding the objectives and process of the study and the potential benefits and risks of participating in the study
Key Trial Info
Start Date :
May 27 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 21 2023
Estimated Enrollment :
93 Patients enrolled
Trial Details
Trial ID
NCT05400785
Start Date
May 27 2022
End Date
December 21 2023
Last Update
March 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Korea University Anam Hospital
Seoul, South Korea